bioRxiv Science⌕ Search

Biology subjects

Brody, J. P.

Publications and source records attributed to Brody, J. P..

2 recordsLinked to original sources

A compact encoding of the genome suitable for machine learning prediction of traits and genetic risk scores.

Genotype to phenotype prediction is a central problem in biology and medicine. Machine learning is a natural tool to address this problem. However, a persons genotype is usually represented by a few million single-nucleotide polymorphisms and most datasets only have a few thousand patients. Thus, this problem typically has many more predictors than the number of samples (patients), making it unsuitable for machine learning. The objective of this paper is to examine the efficacy of a compact genotype representation, which employs a limited number of predictors, in predicting a persons phenotype through the application of machine learning. We characterized a persons genotype using chromosome-scale length variation, a measure that is computed as the average value of reported log R ratios across a portion of a chromosome. We computed these numbers from data collected by the NIH All of Us program. We used the AutoML function (h2o.ai) in binary classification mode to identify the best models to differentiate between male/female, Black/white, white/Asian, and Black/Asian. We also used the AutoML function in regression mode to predict the height of people based on their age and genotype. Our results showed that we could effectively classify a person, using only information from chromosomes 1-22, as Male/Female (AUC=0.9988{+/-}0.0001), White/Black (AUC=0.970{+/-} 0.002), Asian/White (AUC=0.877{+/-} 0.002), and Black/Asian (AUC=0.966{+/-} 0.002). This approach also effectively predicted height. In conclusion, we have shown that this compact representation of a persons genotype, along with machine learning, can effectively predict a persons phenotype.

genomics↗

Analysis of copy number variation from germline DNA can predict individual cancer risk

Inherited factors are thought to be responsible for a substantial fraction of many different forms of cancer. However, individual cancer risk cannot currently be well quantified by analyzing germ line DNA. Most analyses of germline DNA focus on the additive effects of single nucleotide polymorphisms (SNPs) found. Here we show that chromosomal-scale length variation of germline DNA can be used to predict whether a person will develop cancer. In two independent datasets, the Cancer Genome Atlas (TCGA) project and the UK Biobank, we could classify whether or not a patient had a certain cancer based solely on chromosomal scale length variation. In the TCGA data, we found that all 32 different types of cancer could be predicted better than chance using chromosomal scale length variation data. We found a model that could predict ovarian cancer in women with an area under the receiver operator curve, AUC=0.89. In the UK Biobank data, we could predict breast cancer in women with an AUC=0.83. This method could be used to develop genetic risk scores for other conditions known to have a substantial genetic component and complements genetic risk scores derived from SNPs.

genomics↗